Carlyle Group Plans to Sell Up to 10% Stake in Piramal Pharma
We begin with big news in the investment world. Carlyle Group, a major U.S. private equity firm, plans to sell up to a 10% stake in Piramal Pharma, an Indian drugmaker. This move, reported on July 3, could bring in 26 billion to 27 billion rupees, or about $304.8 million, through block trades.
Continue Reading on Meyka
This article is available in full on our main platform. Get access to complete analysis, stock insights, and more.
Read Full Article →
